Abreos Biosciences moNATor

Abreos Biosciences has launched its first commercial product, moNATor, a laboratory-developed test for use by physicians to monitor Tysabri (natalizumab) levels in patients with multiple sclerosis. The test is now commercially available in the US. Abreos' flagship technology is called Veritope, which identifies proprietary peptide-based ligands that can measure and purify biologic molecules. Veritope provides for the selective monitoring of therapeutic antibody drugs, allowing physicians to optimize therapeutic dose and timing.